INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$2.0M

$1,999,995

Total Sells (Filtered)

$292K

$292,776

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
KYTX P Kyverna Therapeutics, Inc. SEIDENBERG BETH C • Director Discretionary BuyΔOwn +18.1% 2025-12-18 $999,998 View Form 4 →
KYTX	Kyverna Therapeutics, Inc.	SEIDENBERG BETH C Director Discretionary BuyΔOwn +18.1%	2025-12-18	$999,998	P	Form 4
KYTX P Kyverna Therapeutics, Inc. Westlake BioPartners Opportunity Fund I, L.P. • 10% Owner Discretionary BuyΔOwn +18.1% 2025-12-18 $999,998 View Form 4 →
KYTX	Kyverna Therapeutics, Inc.	Westlake BioPartners Opportunity Fund I, L.P. 10% Owner Discretionary BuyΔOwn +18.1%	2025-12-18	$999,998	P	Form 4
KYTX M Kyverna Therapeutics, Inc. Walker Karen Marie • CTO Equity Compensation 2025-12-15 $115,910x2 View Form 4 →
KYTX	Kyverna Therapeutics, Inc.	Walker Karen Marie CTO Equity Compensation	2025-12-15	$115,910x2	M	Form 4
KYTX S Kyverna Therapeutics, Inc. Walker Karen Marie • CTO 10b5-1 SellΔOwn -51.5% 2025-12-15 $292,776 View Form 4 →
KYTX	Kyverna Therapeutics, Inc.	Walker Karen Marie CTO 10b5-1 SellΔOwn -51.5%	2025-12-15	$292,776	S	Form 4